Cochrane Abstracts
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus Edited (conclusions changed)
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus Edited (conclusions changed) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alpha‐glucosidase Inhibitors for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Increased Risk of Developing Type 2 Diabetes Mellitus Edited (conclusions Changed)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432100/all/Alpha‐glucosidase_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_of_developing_type_2_diabetes_mellitus_Edited__conclusions_changed_. Accessed 13 August 2022.
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus Edited (conclusions changed). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432100/all/Alpha‐glucosidase_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_of_developing_type_2_diabetes_mellitus_Edited__conclusions_changed_. Accessed August 13, 2022.
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus Edited (conclusions changed). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432100/all/Alpha‐glucosidase_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_of_developing_type_2_diabetes_mellitus_Edited__conclusions_changed_
Alpha‐glucosidase Inhibitors for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Increased Risk of Developing Type 2 Diabetes Mellitus Edited (conclusions Changed) [Internet]. In: Cochrane Abstracts. [cited 2022 August 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432100/all/Alpha‐glucosidase_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_of_developing_type_2_diabetes_mellitus_Edited__conclusions_changed_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus Edited (conclusions changed)
ID - 432100
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432100/all/Alpha‐glucosidase_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_of_developing_type_2_diabetes_mellitus_Edited__conclusions_changed_
DB - Evidence Central
DP - Unbound Medicine
ER -
